Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 17/06/2010
PIL Cosopt Ophthalmic Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/06/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 16/02/2010 and displayed until 17/06/2010
Reasons for adding or updating:
  • Change to storage instructions
Updated on 03/07/2009 and displayed until 16/02/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Extra statutory information
Updated on 29/06/2009 and displayed until 03/07/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 15/06/2009 and displayed until 29/06/2009
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change due to user-testing of patient information
Updated on 13/08/2008 and displayed until 15/06/2009
Reasons for adding or updating:
  • Change to drug interactions
Updated on 25/05/2007 and displayed until 13/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/02/2004 and displayed until 25/05/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 18/02/2003 and displayed until 05/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 25/07/2002 and displayed until 18/02/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 31/10/2001 and displayed until 25/07/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 18/07/2001 and displayed until 31/10/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 17/08/2000 and displayed until 18/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   dorzolamide hydrochloride
   timolol maleate